Advertisement
U.S. markets closed
S&P Futures
5,883.75 -8.75 (-0.15%) Dow Futures
43,029.00 -140.00 (-0.32%) Nasdaq Futures
20,500.25 -41.75 (-0.20%) Russell 2000 Futures
2,243.90 -2.30 (-0.10%) Crude Oil
72.24 +0.15 (+0.21%) Gold
2,760.60 +0.80 (+0.03%)
Glenmark Pharmaceuticals Limited (GLENMARK.BO)
BSE - BSE Real Time Price. Currency in INR
Follow
At close: 03:29PM IST
| Previous Close | 1,715.25 |
| Open | 1,700.15 |
| Bid | 1,686.00 x 0 |
| Ask | 1,690.60 x 0 |
| Day's Range | 1,675.90 - 1,741.95 |
| 52 Week Range | 702.05 - 1,830.05 |
| Volume | |
| Avg. Volume | 24,369 |
| Market Cap | 474.979B |
| Beta (5Y Monthly) | 0.87 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -55.75 |
| Earnings Date | Oct 24, 2024 |
| Forward Dividend & Yield | 2.50 (0.15%) |
| Ex-Dividend Date | Sep 13, 2024 |
| 1y Target Est | 601.93 |
Pharmaceutical TechnologyGlenmark to market BeiGene’s oncology medicines in India
Glenmark will manage the necessary development, registration and distribution processes of Tislelizumab and Zanubrutinib.
Pharmaceutical TechnologyCipla and Glenmark initiate recall of certain products in the US
Cipla USA is recalling 59,244 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.